Global TMF Summit has ended
avatar for Barbara Hepworth-Jones

Barbara Hepworth-Jones

Director, Clinical Development Regulations and Advocacy, Quality & Risk Management, R&D Clinical Operations
Barbara Hepworth-Jones is Director of Quality and Risk Management at GSK. This includes ensuring GSK’s global processes, procedures and training meet current and future regulatory requirements and GCP, and supporting GCP inspection readiness. Barbara has a PhD from the University of Nottingham and started in clinical research 30 years ago as a Clinical Research Associate, subsequently working in clinical trial management, training, and various quality roles, for pharmaceutical companies including GSK and Roche. She is a visiting lecturer at Kings College London.